Targeting the WNT signaling pathway represents a promising strategy for cancer therapy. The field has evolved to include numerous inhibitors currently under preclinical and clinical investigation.
Researchers have identified the mechanism by which cancer cells create their own growth signals to proliferate, independent ...
A new study reveals why some pancreatic and colorectal tumors resist targeted anti-Wnt drugs and suggests how to overcome it, offering new hope to patients with fully treatment-resistant cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback